Azura Ophthalmics Ltd

Azura Ophthalmics Ltd. develops biopharmaceutical solutions for ophthalmic conditions. The Company advances drug discovery and clinical trials for underserved ocular surface diseases, including Meibomian Gland Dysfunction. Azura Ophthalmics Ltd. serves patients with dry eye and related conditions in Australia, the United States, and Israel.